ArticlePloS one2022

Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics.

Robert V House et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.